Metraipolis › archive › dc_285aadd3afb5
Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin — Europe PMC PMID:40937999
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40937999
- DOI
- 10.3390/nano15171320
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:08:22.904Z
- SHA-256 of the archived text
0dd0c5acdbad45d25dc3cc357de484345f23169ae24f46209b281abecc82a5bd- Stable URL of this page
https://metraipolis.com/documento/dc_285aadd3afb5
How to cite
Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin — Europe PMC PMID:40937999 — Europe PMC (en), https://europepmc.org/article/MED/40937999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_285aadd3afb5 (Metraipolis archive dc_285aadd3afb5, sha256 0dd0c5acdbad45d25dc3cc357de484345f23169ae24f46209b281abecc82a5bd)
BibTeX
@misc{dc285aadd3afb5,
title = {Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin — Europe PMC PMID:40937999},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40937999},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_285aadd3afb5; sha256 0dd0c5acdbad45d25dc3cc357de484345f23169ae24f46209b281abecc82a5bd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40937999. Agents can read the archived copy with the MCP tool read_document.